Volunteer for Clinical Research on Opioid Use Disorder

This study is for individuals ages 18-65, who have active opioid use disorder and are interested in receiving long-acting injectable naltrexone injections (Vivitrol®).

This study will test if adding an additional medication called buprenorphine-naloxone will help people stay on long-acting naltrexone injections.

Participants starting treatment with Vivitrol® will be randomly assigned to receive additional buprenorphine or placebo tablets. Random means by chance, it’s like flipping a coin.

You will be monitored over 24 weeks (6 months).

This includes:

- Receiving injectable naltrexone (Vivitrol®) every 4 weeks.

- Weekly sessions with a medical clinician and research (medical check-in, vital sign check, and urine drug screening).

Compensation will be provided after each study visit.

Please call or text 240-739-0626 for more information.